These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 2945735)

  • 41. The epidemiology of AIDS: current status and future prospects.
    Curran JW; Morgan WM; Hardy AM; Jaffe HW; Darrow WW; Dowdle WR
    Science; 1985 Sep; 229(4720):1352-7. PubMed ID: 2994217
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Immunological profile of drug addicts: HTLV-III negative, HTLV-III positive and those with lymphadenopathy syndrome-AIDS related complex].
    Cascavilla N; Martini E; Melillo L; Musto P; Nobile M; Valori VM; Di Giorgio G; Carotenuto M
    Recenti Prog Med; 1987 Mar; 78(3):108-12. PubMed ID: 3648856
    [No Abstract]   [Full Text] [Related]  

  • 43. HTLV-III in saliva of people with AIDS-related complex and healthy homosexual men at risk for AIDS.
    Groopman JE; Salahuddin SZ; Sarngadharan MG; Markham PD; Gonda M; Sliski A; Gallo RC
    Science; 1984 Oct; 226(4673):447-9. PubMed ID: 6093247
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High prevalence and high titers of LAV/HTLV-III antibodies in healthy hemophiliacs in the midwestern United States.
    Goldsmith JC; Dewhurst S; Hedenskog M; Casareale D; Volsky DJ
    Am J Med; 1986 Oct; 81(4):579-83. PubMed ID: 3532787
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Is the HTLV III/LAV virus the causative agent of AIDS or merely an agent of one of the opportunistic infections?].
    Hollán Z
    Orv Hetil; 1986 Dec; 127(52):3219-20. PubMed ID: 2949193
    [No Abstract]   [Full Text] [Related]  

  • 46. Seropositivity to LAV/HTLV-III in 11 European countries.
    Ebbesen P; Melbye M; Jeffries J; Antonen J; Valle SL; Suni J; Ranki A; Krohn K; Chermann JC; Koch MA
    Eur J Cancer Clin Oncol; 1986 Dec; 22(12):1453-6. PubMed ID: 3474150
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The acquired immunodeficiency syndrome: epidemiology and risk factors for transmission.
    Castro KG; Hardy AM; Curran JW
    Med Clin North Am; 1986 May; 70(3):635-49. PubMed ID: 3007891
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Screening test for HTLV-III (AIDS agent) antibodies. Specificity, sensitivity, and applications.
    Weiss SH; Goedert JJ; Sarngadharan MG; Bodner AJ; Gallo RC; Blattner WA
    JAMA; 1985 Jan; 253(2):221-5. PubMed ID: 2981369
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Frequent transmission of HTLV-III among spouses of patients with AIDS-related complex and AIDS.
    Redfield RR; Markham PD; Salahuddin SZ; Sarngadharan MG; Bodner AJ; Folks TM; Ballou WR; Wright DC; Gallo RC
    JAMA; 1985 Mar; 253(11):1571-3. PubMed ID: 2983127
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serological differences between human T-lymphotropic virus type-I (HTLV-I) and HTLV-III/LAV.
    Harada S; Purtilo DT; Koyanagi Y; Yamamoto N
    Microbiol Immunol; 1986; 30(6):533-44. PubMed ID: 3018457
    [TBL] [Abstract][Full Text] [Related]  

  • 51. AIDS and prevalence of antibody to human immunodeficiency virus (HIV) in high risk groups in Thailand.
    Traisupa A; Wongba C; Taylor DN
    Genitourin Med; 1987 Apr; 63(2):106-8. PubMed ID: 3646990
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Walter Reed staging classification for HTLV-III/LAV infection.
    Redfield RR; Wright DC; Tramont EC
    N Engl J Med; 1986 Jan; 314(2):131-2. PubMed ID: 2934633
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human T cell leukemia virus type III antibody, lymphadenopathy, and acquired immune deficiency syndrome in hemophiliac subjects. Results of a prospective study.
    Kreiss JK; Kitchen LW; Prince HE; Kasper CK; Goldstein AL; Naylor PH; Preble O; Stewart JA; Essex M
    Am J Med; 1986 Mar; 80(3):345-50. PubMed ID: 3006485
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome.
    Ho DD; Rota TR; Schooley RT; Kaplan JC; Allan JD; Groopman JE; Resnick L; Felsenstein D; Andrews CA; Hirsch MS
    N Engl J Med; 1985 Dec; 313(24):1493-7. PubMed ID: 2999591
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impairment of cellular immunity and OKT4 lymphocytes in symptom-free hemophiliacs with antibodies to human T leukemia virus III (HTLV III).
    Pandolfi F; De Rossi G; Mariani G; Carbonari M; Ensoli B; Napolitano M; Lopez M; Mandelli F; Aiuti F
    Diagn Immunol; 1985; 3(3):155-9. PubMed ID: 2996821
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Vancouver Lymphadenopathy-AIDS Study: 3. Relation of HTLV-III seropositivity, immune status and lymphadenopathy.
    Boyko WJ; Schechter MT; Jeffries E; Douglas B; Maynard M; O'Shaughnessy M
    Can Med Assoc J; 1985 Jul; 133(1):28-32. PubMed ID: 2988730
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum beta 2-microglobulin and interferon in homosexual males: relationship to clinical findings and serologic status to the human T lymphotropic virus (HTLV-III).
    Calabrese LH; Proffitt MR; Gupta MK; Easley KA; Walker JR; Rehm SJ; Valenzuela R; Clough JD
    AIDS Res; 1984-1985; 1(6):423-38. PubMed ID: 6085927
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antibodies to human T-lymphotropic virus type III (HTLV-III) in saliva of acquired immunodeficiency syndrome (AIDS) patients and in persons at risk for AIDS.
    Archibald DW; Zon L; Groopman JE; McLane MF; Essex M
    Blood; 1986 Mar; 67(3):831-4. PubMed ID: 3484980
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epidemiology of human lymphotrophic retroviruses: an overview.
    Blattner WA; Biggar RJ; Weiss SH; Clark JW; Goedert JJ
    Cancer Res; 1985 Sep; 45(9 Suppl):4598s-4601s. PubMed ID: 2990691
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HTLV-III infection among health care workers. Association with needle-stick injuries.
    Weiss SH; Saxinger WC; Rechtman D; Grieco MH; Nadler J; Holman S; Ginzburg HM; Groopman JE; Goedert JJ; Markham PD
    JAMA; 1985 Oct; 254(15):2089-93. PubMed ID: 2995694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.